Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price reached a new 52-week low on Thursday . The company traded as low as GBX 1.60 ($0.02) and last traded at GBX 1.68 ($0.02), with a volume of 1275106 shares trading hands. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Price Performance
The firm has a market cap of £6.64 million, a PE ratio of 168.00 and a beta of 0.35. The business has a fifty day moving average price of GBX 2 and a two-hundred day moving average price of GBX 2.12.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- How to Choose Top Rated Stocks
- Meta Stock: 3 Reasons This Stumble Is a Golden Buying Opportunity
- How to Evaluate a Stock Before Buying
- 3 Staples Stocks to Cushion Lower Consumer Sentiment
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Zillow’s Earnings Dip: An Opportunity for Visionaries
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
